Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-12

FDA Approved: CLINDAMYCIN PHOSPHATE AND TRETINOIN — Original Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a fixed-dose topical combination of clindamycin phosphate and tretinoin from Actavis Pharma, Inc. under an Original Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin Phosphate and Tretinoin (Clindamycin phosphate and tretinoin)

Snippet

ORIG AP for CLINDAMYCIN PHOSPHATE AND TRETINOIN (CLINDAMYCIN PHOSPHATE AND TRETINOIN)